Bridging the Gap: The Critical Role of Regulatory Affairs and Clinical Affairs in the Total Product Life Cycle of Pathology Imaging Devices and Software

Manufacturers of pathology imaging devices and associated software engage regulatory affairs and clinical affairs (RACA) throughout the Total Product Life Cycle (TPLC) of regulated products. A number of manufacturers, pathologists, and end users are not familiar with how RACA involvement benefits ea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Staci J. Kearney, Amanda Lowe, Jochen K. Lennerz, Anil Parwani, Marilyn M. Bui, Katy Wack, Gina Giannini, Esther Abels
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/34f8f7360ab14310a50c7eddd8b3501f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:34f8f7360ab14310a50c7eddd8b3501f
record_format dspace
spelling oai:doaj.org-article:34f8f7360ab14310a50c7eddd8b3501f2021-11-17T05:35:53ZBridging the Gap: The Critical Role of Regulatory Affairs and Clinical Affairs in the Total Product Life Cycle of Pathology Imaging Devices and Software2296-858X10.3389/fmed.2021.765385https://doaj.org/article/34f8f7360ab14310a50c7eddd8b3501f2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.765385/fullhttps://doaj.org/toc/2296-858XManufacturers of pathology imaging devices and associated software engage regulatory affairs and clinical affairs (RACA) throughout the Total Product Life Cycle (TPLC) of regulated products. A number of manufacturers, pathologists, and end users are not familiar with how RACA involvement benefits each stage of the TPLC. RACA professionals are important contributors to product development and deployment strategies because these professionals maintain an understanding of the scientific, technical, and clinical aspects of biomedical product regulation, as well as the relevant knowledge of regulatory requirements, policies, and market trends for both local and global regulations and standards. Defining a regulatory and clinical strategy at the beginning of product design enables early evaluation of risks and provides assurance that the collected evidence supports the product's clinical claims (e.g., in a marketing application), its safe and effective use, and potential reimbursement strategies. It is recommended to involve RACA early and throughout the TPLC to assist with navigating changes in the regulatory environment and dynamic diagnostic market. Here we outline how various stakeholders can utilize RACA to navigate the nuanced landscape behind the development and use of clinical diagnostic products. Collectively, this work emphasizes the critical importance of RACA as an integral part of product development and, thereby, sustained innovation.Staci J. KearneyAmanda LoweJochen K. LennerzAnil ParwaniMarilyn M. BuiKaty WackGina GianniniEsther AbelsFrontiers Media S.A.articleregulatory strategyclinical affairstotal product life cyclein vitro diagnostics developmentdigital pathologybusiness strategyMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic regulatory strategy
clinical affairs
total product life cycle
in vitro diagnostics development
digital pathology
business strategy
Medicine (General)
R5-920
spellingShingle regulatory strategy
clinical affairs
total product life cycle
in vitro diagnostics development
digital pathology
business strategy
Medicine (General)
R5-920
Staci J. Kearney
Amanda Lowe
Jochen K. Lennerz
Anil Parwani
Marilyn M. Bui
Katy Wack
Gina Giannini
Esther Abels
Bridging the Gap: The Critical Role of Regulatory Affairs and Clinical Affairs in the Total Product Life Cycle of Pathology Imaging Devices and Software
description Manufacturers of pathology imaging devices and associated software engage regulatory affairs and clinical affairs (RACA) throughout the Total Product Life Cycle (TPLC) of regulated products. A number of manufacturers, pathologists, and end users are not familiar with how RACA involvement benefits each stage of the TPLC. RACA professionals are important contributors to product development and deployment strategies because these professionals maintain an understanding of the scientific, technical, and clinical aspects of biomedical product regulation, as well as the relevant knowledge of regulatory requirements, policies, and market trends for both local and global regulations and standards. Defining a regulatory and clinical strategy at the beginning of product design enables early evaluation of risks and provides assurance that the collected evidence supports the product's clinical claims (e.g., in a marketing application), its safe and effective use, and potential reimbursement strategies. It is recommended to involve RACA early and throughout the TPLC to assist with navigating changes in the regulatory environment and dynamic diagnostic market. Here we outline how various stakeholders can utilize RACA to navigate the nuanced landscape behind the development and use of clinical diagnostic products. Collectively, this work emphasizes the critical importance of RACA as an integral part of product development and, thereby, sustained innovation.
format article
author Staci J. Kearney
Amanda Lowe
Jochen K. Lennerz
Anil Parwani
Marilyn M. Bui
Katy Wack
Gina Giannini
Esther Abels
author_facet Staci J. Kearney
Amanda Lowe
Jochen K. Lennerz
Anil Parwani
Marilyn M. Bui
Katy Wack
Gina Giannini
Esther Abels
author_sort Staci J. Kearney
title Bridging the Gap: The Critical Role of Regulatory Affairs and Clinical Affairs in the Total Product Life Cycle of Pathology Imaging Devices and Software
title_short Bridging the Gap: The Critical Role of Regulatory Affairs and Clinical Affairs in the Total Product Life Cycle of Pathology Imaging Devices and Software
title_full Bridging the Gap: The Critical Role of Regulatory Affairs and Clinical Affairs in the Total Product Life Cycle of Pathology Imaging Devices and Software
title_fullStr Bridging the Gap: The Critical Role of Regulatory Affairs and Clinical Affairs in the Total Product Life Cycle of Pathology Imaging Devices and Software
title_full_unstemmed Bridging the Gap: The Critical Role of Regulatory Affairs and Clinical Affairs in the Total Product Life Cycle of Pathology Imaging Devices and Software
title_sort bridging the gap: the critical role of regulatory affairs and clinical affairs in the total product life cycle of pathology imaging devices and software
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/34f8f7360ab14310a50c7eddd8b3501f
work_keys_str_mv AT stacijkearney bridgingthegapthecriticalroleofregulatoryaffairsandclinicalaffairsinthetotalproductlifecycleofpathologyimagingdevicesandsoftware
AT amandalowe bridgingthegapthecriticalroleofregulatoryaffairsandclinicalaffairsinthetotalproductlifecycleofpathologyimagingdevicesandsoftware
AT jochenklennerz bridgingthegapthecriticalroleofregulatoryaffairsandclinicalaffairsinthetotalproductlifecycleofpathologyimagingdevicesandsoftware
AT anilparwani bridgingthegapthecriticalroleofregulatoryaffairsandclinicalaffairsinthetotalproductlifecycleofpathologyimagingdevicesandsoftware
AT marilynmbui bridgingthegapthecriticalroleofregulatoryaffairsandclinicalaffairsinthetotalproductlifecycleofpathologyimagingdevicesandsoftware
AT katywack bridgingthegapthecriticalroleofregulatoryaffairsandclinicalaffairsinthetotalproductlifecycleofpathologyimagingdevicesandsoftware
AT ginagiannini bridgingthegapthecriticalroleofregulatoryaffairsandclinicalaffairsinthetotalproductlifecycleofpathologyimagingdevicesandsoftware
AT estherabels bridgingthegapthecriticalroleofregulatoryaffairsandclinicalaffairsinthetotalproductlifecycleofpathologyimagingdevicesandsoftware
_version_ 1718425851944501248